Great to see TSI advancing the adoption of BFPC.
We are very pleased to see TSI highlighting the collaboration among major pharmaceutical manufacturing businesses to advance the adoption of Biofluorescent Particle Counters (BFPC).
We are very pleased to see TSI highlighting the collaboration among major pharmaceutical manufacturing businesses to advance the adoption of Biofluorescent Particle Counters (BFPC).
Keeping up the publicity momentum with our business partners from Astech, we will be exhibiting at the Ireland Biomanufacturing Summit at the Crowne Plaza Hotel in Dublin on 28th & 29th February.
We will be exhibiting with our new Ireland business partner, Astech, at the Biopharma & Life Sciences Connected Live event on 25th January at the Radisson Blu Hotel in Cork. Mike Dingle, TSI's BioTrak expert, will present a paper on BFPC to show how it is an ideal solution for meeting Annex 1 viable air testing requirements.
Conor Murray, BioTrak® Real-Time Viable Particle Counter product specialist in Ireland, will present a paper entitled 'Annex 1 – a “Call to Action” to adopt new technology and mitigate risks in support of Pharma 4.0' at the Cleanroom Technology Conference in Singapore.